CO-DIAGNOSTICS, INC. (CODX) Operating income 2016–2025
CO-DIAGNOSTICS, INC. (CODX) annual operating income history from SEC filings — each fiscal year as reported.
-$50.2MFY2025 · since FY2016: -$1.7M → -$50.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$50.2M | -25.2% |
| FY2024 | -$40.1M | +6.1% |
| FY2023 | -$42.7M | -58.3% |
| FY2022 | -$27.0M | -158.6% |
| FY2021 | $46.1M | +10.5% |
| FY2020 | $41.7M | +807.4% |
| FY2019 | -$5.9M | +3.7% |
| FY2018 | -$6.1M | -34.0% |
| FY2017 | -$4.6M | -170.4% |
| FY2016 | -$1.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CODX financial trends
CODX RevenueCODX Net incomeCODX Net marginCODX Gross profitCODX Gross marginCODX Operating marginCODX Operating cash flowCODX Free cash flowCODX Capital expendituresCODX Return on equityCODX Stock buybacksCODX Dividends paidCODX Total assetsCODX Total liabilitiesCODX Shareholders’ equityCODX overview →